{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:36:27Z","timestamp":1784864187483,"version":"3.55.0"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1P01AI168258-01"],"award-info":[{"award-number":["1P01AI168258-01"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["2P01HL131478-06A1"],"award-info":[{"award-number":["2P01HL131478-06A1"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00259-025-07281-4","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:16:50Z","timestamp":1745799410000},"page":"4717-4734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiolabeling lipoproteins to study and manage disease"],"prefix":"10.1007","volume":"52","author":[{"given":"Carlos","family":"P\u00e9rez-Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J. M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0401-8262","authenticated-orcid":false,"given":"Abraham J. P.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"7281_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1146\/annurev-biochem-061009-102430","volume":"81","author":"TC Walther","year":"2012","unstructured":"Walther TC, Farese RV. Lipid droplets and cellular lipid metabolism. Annu Rev Biochem. 2012;81:687\u2013714.","journal-title":"Annu Rev Biochem"},{"key":"7281_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrm.2017.138","volume":"19","author":"T Harayama","year":"2018","unstructured":"Harayama T, Riezman H. Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol. 2018;19:281\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7281_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","volume":"23","author":"W Wahli","year":"2012","unstructured":"Wahli W, Michalik L. PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab. 2012;23:351\u201363.","journal-title":"Trends Endocrinol Metab"},{"key":"7281_CR4","doi-asserted-by":"publisher","first-page":"113458","DOI":"10.1016\/j.celrep.2023.113458","volume":"42","author":"N Rother","year":"2023","unstructured":"Rother N, et al. Acid ceramidase regulates innate immune memory. Cell Rep. 2023;42:113458.","journal-title":"Cell Rep"},{"key":"7281_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1172\/JCI71610","volume":"124","author":"GJ Randolph","year":"2014","unstructured":"Randolph GJ, Miller NE. Lymphatic transport of high-density lipoproteins and chylomicrons. J Clin Invest. 2014;124:929\u201335.","journal-title":"J Clin Invest"},{"key":"7281_CR6","doi-asserted-by":"crossref","unstructured":"Jonas A, Phillips MC. Lipoprotein structure. Biochemistry of lipids, lipoproteins and membranes. Amsterdam: Elsevier Netherlands; 2008.","DOI":"10.1016\/B978-044453219-0.50019-2"},{"key":"7281_CR7","unstructured":"Feingold KR, Grunfeld C. Introduction to lipids and lipoproteins. South Dartmouth: MDTExt.com, Inc; 2024."},{"key":"7281_CR8","doi-asserted-by":"publisher","first-page":"1254753","DOI":"10.3389\/fimmu.2023.1254753","volume":"14","author":"J Yan","year":"2023","unstructured":"Yan J, et al. Dyslipidemia in rheumatoid arthritis: the possible mechanisms. Front Immunol. 2023;14:1254753.","journal-title":"Front Immunol"},{"key":"7281_CR9","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(20)32233-9","volume":"396","author":"MB Mortensen","year":"2020","unstructured":"Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70\u2013100 years: a contemporary primary prevention cohort. The Lancet. 2020;396:1644\u201352.","journal-title":"The Lancet"},{"key":"7281_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1161\/hc3501.095214","volume":"104","author":"AR Sharrett","year":"2001","unstructured":"Sharrett AR, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001;104:1108\u201313.","journal-title":"Circulation"},{"key":"7281_CR11","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.1073\/pnas.1016086108","volume":"108","author":"JE Feig","year":"2011","unstructured":"Feig JE, et al. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proceed Natl Acad Sci. 2011;108:7166\u201371.","journal-title":"Proceed Natl Acad Sci"},{"key":"7281_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0022-2275(20)39245-2","volume":"7","author":"JA Glomset","year":"1966","unstructured":"Glomset JA, Janssen ET, Kennedy R, Dobbins J. Role of plasma lecithin:cholesterol acyltransferase in the metabolism of high density lipoproteins. J Lipid Res. 1966;7:639\u201348.","journal-title":"J Lipid Res"},{"key":"7281_CR13","doi-asserted-by":"crossref","unstructured":"Weinstein DB, Carew TE, Steinberg D (1976) Uptake and degradation of low density lipoprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesis. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism. 424(3):404-21.","DOI":"10.1016\/0005-2760(76)90030-8"},{"key":"7281_CR14","doi-asserted-by":"publisher","first-page":"12040","DOI":"10.1073\/pnas.90.24.12040","volume":"90","author":"DM Levine","year":"1993","unstructured":"Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci. 1993;90:12040\u20134.","journal-title":"Proc Natl Acad Sci"},{"key":"7281_CR15","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1128\/iai.61.12.5140-5146.1993","volume":"61","author":"WA Flegel","year":"1993","unstructured":"Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun. 1993;61:5140\u20136.","journal-title":"Infect Immun"},{"key":"7281_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"KC Vickers","year":"2011","unstructured":"Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423\u201333.","journal-title":"Nat Cell Biol"},{"key":"7281_CR17","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","volume":"124","author":"M Ouimet","year":"2019","unstructured":"Ouimet M, Barrett TJ, Fisher EA. HDL and Reverse Cholesterol Transport. Circ Res. 2019;124:1505\u201318.","journal-title":"Circ Res"},{"key":"7281_CR18","doi-asserted-by":"publisher","first-page":"8180424","DOI":"10.1155\/2021\/8180424","volume":"2021","author":"L Maran","year":"2021","unstructured":"Maran L, Hamid A, Bariyah S, Hamid S, Wertz PW. Lipoproteins as Markers for Monitoring Cancer Progression. J Lipids. 2021;2021:8180424.","journal-title":"J Lipids"},{"key":"7281_CR19","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1002\/adfm.201602600","volume":"26","author":"KM McMahon","year":"2016","unstructured":"McMahon KM, Plebanek MP, Thaxton CS. Properties of Native High-Density Lipoproteins Inspire Synthesis of Actively Targeted In Vivo siRNA Delivery Vehicles. Adv Funct Mater. 2016;26:7824\u201335.","journal-title":"Adv Funct Mater"},{"key":"7281_CR20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/ar200017e","volume":"44","author":"KK Ng","year":"2011","unstructured":"Ng KK, Lovell JF, Zheng G. Lipoprotein-inspired nanoparticles for cancer theranostics. Acc Chem Res. 2011;44:1105\u201313.","journal-title":"Acc Chem Res"},{"key":"7281_CR21","first-page":"1","volume":"7","author":"MMT van Leent","year":"2021","unstructured":"van Leent MMT, et al. A modular approach toward producing nanotherapeutics targeting the innate immune system. Sci Adv. 2021;7:1\u201312.","journal-title":"Sci Adv"},{"key":"7281_CR22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.cell.2020.09.059","volume":"183","author":"B Priem","year":"2020","unstructured":"Priem B, et al. Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition. Cell. 2020;183:786\u2013801.","journal-title":"Cell"},{"key":"7281_CR23","doi-asserted-by":"publisher","first-page":"7736","DOI":"10.1126\/scitranslmed.aaw7736","volume":"11","author":"T Binderup","year":"2019","unstructured":"Binderup T, et al. Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species. Sci Transl Med. 2019;11:7736.","journal-title":"Sci Transl Med"},{"key":"7281_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1148\/radiology.219.2.r01ma19316","volume":"219","author":"R Weissleder","year":"2001","unstructured":"Weissleder R, Mahmood U. Molecular imaging. Radiology. 2001;219:316\u201333.","journal-title":"Radiology"},{"key":"7281_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1161\/ATVBAHA.108.179275","volume":"30","author":"T Skajaa","year":"2010","unstructured":"Skajaa T, et al. High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30:169\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7281_CR26","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2147\/IJN.S122036","volume":"12","author":"S Sabnis","year":"2017","unstructured":"Sabnis S, Sabnis NA, Raut S, Lacko AG. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery. Int J Nanomedicine. 2017;12:1453\u201364.","journal-title":"Int J Nanomedicine"},{"key":"7281_CR27","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1021\/acs.chemmater.6b05357","volume":"29","author":"V Nandwana","year":"2017","unstructured":"Nandwana V, et al. High-Density Lipoprotein-like Magnetic Nanostructures (HDL-MNS): Theranostic Agents for Cardiovascular Disease. Chem Mater. 2017;29:2276\u201382.","journal-title":"Chem Mater"},{"key":"7281_CR28","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1021\/bc400105j","volume":"24","author":"A Barazza","year":"2013","unstructured":"Barazza A, et al. The complex fate in plasma of gadolinium incorporated into high-density lipoproteins used for magnetic imaging of atherosclerotic plaques. Bioconjug Chem. 2013;24:1039\u201348.","journal-title":"Bioconjug Chem"},{"key":"7281_CR29","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1021\/jp8108286","volume":"113","author":"KC Briley-Saebo","year":"2009","unstructured":"Briley-Saebo KC, et al. High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agents. J Phys Chem B. 2009;113:6283\u20139.","journal-title":"J Phys Chem B"},{"key":"7281_CR30","doi-asserted-by":"crossref","unstructured":"Skajaa T, et al, Mulder WJ (2009) Nanotechnology in medical imaging: probe design and applications. Arteriosclerosis, thrombosis, and vascular biology. 29(7):992-1000.","DOI":"10.1161\/ATVBAHA.108.165506"},{"key":"7281_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1593\/neo.07682","volume":"9","author":"SG Crich","year":"2007","unstructured":"Crich SG, et al. Magnetic Resonance Imaging Detection of Tumor Cells by Targeting Low-Density Lipoprotein Receptors with Gd-Loaded Low-Density Lipoprotein Particles. Neoplasia. 2007;9:1046\u201356.","journal-title":"Neoplasia"},{"key":"7281_CR32","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1021\/ja808856z","volume":"131","author":"CS Thaxton","year":"2009","unstructured":"Thaxton CS, Daniel WL, Giljohann DA, Thomas AD, Mirkin CA. Templated spherical high density lipoprotein nanoparticles. J Am Chem Soc. 2009;131:1384\u20135.","journal-title":"J Am Chem Soc"},{"key":"7281_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/0005-2760(84)90156-5","volume":"794","author":"JB Massey","year":"1984","unstructured":"Massey JB, et al. Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteins. Biochimica et Biophysica Acta - Lipids and Lipid Metabolism. 1984;794:274\u201380.","journal-title":"Biochimica et Biophysica Acta - Lipids and Lipid Metabolism"},{"key":"7281_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0005-2760(78)90215-1","volume":"531","author":"GW Melchior","year":"1978","unstructured":"Melchior GW, Rudel LL. Heterogeneity in the low density lipoproteins of cholesterol fed African green monkeys (Cercopithecus aethiops). Biochimica et Biophysica Acta - Lipids and Lipid Metabolism. 1978;531:331\u201343.","journal-title":"Biochimica et Biophysica Acta - Lipids and Lipid Metabolism"},{"key":"7281_CR35","doi-asserted-by":"crossref","unstructured":"Eisenberg S, Rachmilewitz D. Metabolism of rat plasma very low density lipoprotein: I fate in circulation of the whole lipoprotein. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism. 1973 Dec 20;326(3):378-90.","DOI":"10.1016\/0005-2760(73)90139-2"},{"key":"7281_CR36","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0022-2275(20)38785-X","volume":"27","author":"G Ghiselli","year":"1988","unstructured":"Ghiselli G, Krishnan S, Beigel Y, Gotto AM. Plasma metabolism of apolipoprotein A-IV in humans. J Lipid Res. 1988;27:813\u201327.","journal-title":"J Lipid Res"},{"key":"7281_CR37","doi-asserted-by":"crossref","unstructured":"Van Berkel TJ, De Rijke YB, Kruijt JK. Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem. 1991;266(4):2282\u20139.","DOI":"10.1016\/S0021-9258(18)52241-9"},{"key":"7281_CR38","doi-asserted-by":"publisher","first-page":"32692","DOI":"10.1074\/jbc.274.46.32692","volume":"274","author":"H Stangl","year":"1999","unstructured":"Stangl H, Hyatt M, Hobbs HH. Transport of lipids from high and low density lipoproteins via scavenger receptor-BI. J Biol Chem. 1999;274:32692\u20138.","journal-title":"J Biol Chem"},{"key":"7281_CR39","doi-asserted-by":"crossref","unstructured":"Daerr WH, Pethke W, Windler ETE, Greten H (1990) Biotinyl-high-density lipoproteins as a probe for the determination of high-density lipoprotein turnover in humans. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1043, 311\u2013317","DOI":"10.1016\/0005-2760(90)90032-S"},{"key":"7281_CR40","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1172\/JCI108229","volume":"56","author":"G Sigurdsson","year":"1975","unstructured":"Sigurdsson G, Nicoll A. Lewis B Conversion of very low density lipoprotein to low density lipoprotein A metabolic study of apolipoprotein B kinetics in human subjects. J Clin Invest. 1975;56:1481\u201390.","journal-title":"J Clin Invest"},{"key":"7281_CR41","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0955-2863(96)00106-4","volume":"7","author":"S Kubow","year":"1996","unstructured":"Kubow S. The influence of positional distribution of fatty acids in native, interesterified and structure-specific lipids on lipoprotein metabolism and atherogenesis. J Nutr Biochem. 1996;7:530\u201341.","journal-title":"J Nutr Biochem"},{"key":"7281_CR42","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1172\/JCI110717","volume":"70","author":"IJ Goldberg","year":"1982","unstructured":"Goldberg IJ, et al. Lipoprotein Metabolism during Acute Inhibition of Hepatic Triglyceride Lipase in the Cynomolgus Monkey. J Clin Invest. 1982;70:1184\u201392.","journal-title":"J Clin Invest"},{"key":"7281_CR43","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0022-2275(20)34460-6","volume":"25","author":"RE Gregg","year":"1984","unstructured":"Gregg RE, Zech LA, Schaefer EJ, Brewer HB. Apolipoprotein E metabolism in normolipoproteinemic human subjects. J Lipid Res. 1984;25:1167\u201376.","journal-title":"J Lipid Res"},{"key":"7281_CR44","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0022-2275(20)41639-6","volume":"32","author":"DJ Rader","year":"1991","unstructured":"Rader DJ, Castro G, Zech LA, Fruchart JC, Brewer HB. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I. A-II J Lipid Res. 1991;32:1849\u201359.","journal-title":"A-II J Lipid Res"},{"key":"7281_CR45","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0022-2275(20)40545-0","volume":"33","author":"YB De Rijke","year":"1992","unstructured":"De Rijke YB, Jurgens G, Hessels EMAJ, Hermann A, Van Berkel TJC. In vivo fate and scavenger receptor recognition of oxidized lipoprotein[a] isoforms in rats. J Lipid Res. 1992;33:1315\u201325.","journal-title":"J Lipid Res"},{"issue":"271","key":"7281_CR46","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1126\/science.271.5248.518","volume":"1979","author":"S Acton","year":"1996","unstructured":"Acton S, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 1996;1979(271):518\u201320.","journal-title":"Science"},{"key":"7281_CR47","doi-asserted-by":"publisher","first-page":"7599","DOI":"10.1073\/pnas.81.23.7599","volume":"81","author":"M Huettinger","year":"1984","unstructured":"Huettinger M, et al. Imaging of hepatic low density lipoprotein receptors by radionuclide scintiscanning in vivo. Proc Natl Acad Sci. 1984;81:7599\u2013603.","journal-title":"Proc Natl Acad Sci"},{"key":"7281_CR48","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0022-2275(20)38749-6","volume":"27","author":"RE Morton","year":"1990","unstructured":"Morton RE, West GA, Hoff HF. A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism. J Lipid Res. 1990;27:1124\u201334.","journal-title":"J Lipid Res"},{"key":"7281_CR49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1161\/01.ATV.15.1.112","volume":"15","author":"F Tat\u00f2","year":"1995","unstructured":"Tat\u00f2 F, Vega GL, Tall AR, Grundy SM. Relation Between Cholesterol Ester Transfer Protein Activities and Lipoprotein Cholesterol in Patients With Hypercholesterolemia and Combined Hyperlipidemia. Arterioscler Thromb Vasc Biol. 1995;15:112\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7281_CR50","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1161\/01.ATV.13.5.702","volume":"13","author":"MJ Caslake","year":"1993","unstructured":"Caslake MJ, et al. Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia. Arterioscler Thromb. 1993;13:702\u201311.","journal-title":"Arterioscler Thromb"},{"key":"7281_CR51","doi-asserted-by":"crossref","unstructured":"Ginsberg HN, Goldsmith SJ, Vallabhajosula S. Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients. Arteriosclerosis: An Official J Am Heart Assoc, Inc. 1990 Mar;10(2):256-62.","DOI":"10.1161\/01.ATV.10.2.256"},{"key":"7281_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0021-9150(96)05888-1","volume":"126","author":"L Iuliano","year":"1996","unstructured":"Iuliano L, et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis. 1996;126:131\u201341.","journal-title":"Atherosclerosis"},{"key":"7281_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/01.ATV.13.1.78","volume":"13","author":"DE Atsma","year":"1993","unstructured":"Atsma DE, et al. Potential of 99mTc-LDLs labeled by two different methods for scintigraphic detection of experimental atherosclerosis in rabbits. Arterioscler Thromb. 1993;13:78\u201383.","journal-title":"Arterioscler Thromb"},{"key":"7281_CR54","doi-asserted-by":"publisher","first-page":"8518","DOI":"10.1021\/bi00084a018","volume":"32","author":"MY Chang","year":"1993","unstructured":"Chang MY, Lees AM, Lees RS. Low-Density Lipoprotein Modification and Arterial Wall Accumulation in a Rabbit Model of Atherosclerosis. Biochemistry. 1993;32:8518\u201324.","journal-title":"Biochemistry"},{"key":"7281_CR55","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1023\/A:1018881904228","volume":"16","author":"W Xiao","year":"1999","unstructured":"Xiao W, Wang L, Scott T, Counsell RE, Liu H. Radiolabeled cholesteryl lopanoate\/ acetylated low density lipoprotein as a potential probe for visualization of early atherosclerotic lesions in rabbits. Pharm Res. 1999;16:420\u20136.","journal-title":"Pharm Res"},{"key":"7281_CR56","first-page":"461","volume":"8","author":"An Official Journal of the American Heart Association","year":"1988","unstructured":"An Official Journal of the American Heart Association. Lees, A. M. et al. Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins. Arteriosclerosis. Inc. 1988;8:461\u201370.","journal-title":"Inc"},{"key":"7281_CR57","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/01.CIR.101.11.1249","volume":"101","author":"L Iuliano","year":"2000","unstructured":"Iuliano L, Mauriello A, Sbarigia E, Spagnoli LG, Violi F. Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: Effect of vitamin E supplementation. Circulation. 2000;101:1249\u201354.","journal-title":"Circulation"},{"key":"7281_CR58","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1124\/mol.52.3.542","volume":"52","author":"AH Taylor","year":"1997","unstructured":"Taylor AH, Stephan ZF, Steele RE, Wong NCW. Beneficial Effects of a Novel Thyromimetic on Lipoprotein Metabolism. Mol Pharmacol. 1997;52:542\u20137.","journal-title":"Mol Pharmacol"},{"key":"7281_CR59","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1073\/pnas.80.13.4124","volume":"80","author":"DW Bilheimer","year":"1983","unstructured":"Bilheimer DW, Grundy SM, Brown MS, Goldstein JL. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci. 1983;80:4124\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"7281_CR60","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0026-0495(86)90236-2","volume":"35","author":"A Chait","year":"1986","unstructured":"Chait A, Foster DM, Albers JJ, Failor RA, Brunzell JD. Low density lipoprotein metabolism in familial combined hyperlipidemia and familial hypercholesterolemia: Kinetic analysis using an integrated model. Metabolism. 1986;35:697\u2013704.","journal-title":"Metabolism"},{"issue":"3","key":"7281_CR61","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ijc.2910540311","volume":"54","author":"E Ponty","year":"1993","unstructured":"Ponty E, Carton M, Soula G, Favre G, Benaniba R, Boneu A, Lucot H. Biodistribution study of 99mTc-labeled LDL in B16-melanoma-bearing mice Visualization of a preferential uptake by the tumor. Int J Cancer. 1993;54(3):411\u20137.","journal-title":"Int J Cancer"},{"key":"7281_CR62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1021\/bc950073l","volume":"7","author":"F Jasanada","year":"1996","unstructured":"Jasanada F, et al. Indium-111 labeling of low density lipoproteins with the DTPA-Bis(stearylamide): evaluation as a potential radiopharmaceutical for tumor localization. Bioconjug Chem. 1996;7:72\u201381.","journal-title":"Bioconjug Chem"},{"key":"7281_CR63","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/0016-5085(83)90431-6","volume":"85","author":"P Monroe","year":"1983","unstructured":"Monroe P, Vlahcevic ZR, Swell L. In vivo evaluation of lipoprotein cholesterol ester metabolism in patients with liver disease. Gastroenterology. 1983;85:820\u20139.","journal-title":"Gastroenterology"},{"key":"7281_CR64","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0026-0495(97)90305-X","volume":"46","author":"PD Thompson","year":"1997","unstructured":"Thompson PD, et al. Effect of prolonged exercise training without weight loss on high-density lipoprotein metabolism in overweight men. Metabolism. 1997;46:217\u201323.","journal-title":"Metabolism"},{"key":"7281_CR65","doi-asserted-by":"publisher","first-page":"208","DOI":"10.7326\/0003-4819-110-3-208","volume":"110","author":"S Vallabhajosula","year":"1989","unstructured":"Vallabhajosula S, et al. Low density lipoprotein (LDL) distribution shown by 99mTechnetium-LDL imaging in patients with myeloproliferative diseases. Ann Intern Med. 1989;110:208\u201313.","journal-title":"Ann Intern Med"},{"key":"7281_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11838","volume":"7","author":"C Perez-Medina","year":"2016","unstructured":"Perez-Medina C, et al. Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. Nat Commun. 2016;7:1\u20138.","journal-title":"Nat Commun"},{"key":"7281_CR67","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.jcmg.2018.07.027","volume":"12","author":"ML Senders","year":"2019","unstructured":"Senders ML, et al. Nanobody-Facilitated Multiparametric PET\/MRI Phenotyping of Atherosclerosis. JACC Cardiovasc Imaging. 2019;12:2015\u201326.","journal-title":"JACC Cardiovasc Imaging"},{"key":"7281_CR68","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41551-018-0221-2","volume":"2","author":"M Lameijer","year":"2018","unstructured":"Lameijer M, et al. Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates. Nat Biomed Eng. 2018;2:279\u201392.","journal-title":"Nat Biomed Eng"},{"key":"7281_CR69","first-page":"1","volume":"2023","author":"DP Schrijver","year":"2023","unstructured":"Schrijver DP, et al. Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells. Nature Biomed Eng. 2023;2023:1\u201316.","journal-title":"Nature Biomed Eng"},{"key":"7281_CR70","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.2967\/jnumed.121.263330","volume":"63","author":"KH Zheng","year":"2022","unstructured":"Zheng KH, et al. 89Zr-labeled high-density lipoprotein nanoparticle pet imaging reveals tumor uptake in patients with esophageal cancer. J Nucl Med. 2022;63:1880\u20136.","journal-title":"J Nucl Med"},{"key":"7281_CR71","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/182053a0","volume":"182","author":"AS McFarlane","year":"1958","unstructured":"McFarlane AS. Efficient Trace-labelling of Proteins with Iodine. Nature. 1958;182:53\u201353.","journal-title":"Nature"},{"key":"7281_CR72","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0022-2275(20)30279-0","volume":"42","author":"KW Huggins","year":"2001","unstructured":"Huggins KW, et al. Dietary n-3 polyunsaturated fat increases the fractional catabolic rate of medium-sized HDL particles in African green monkeys. J Lipid Res. 2001;42:1457\u201366.","journal-title":"J Lipid Res"},{"key":"7281_CR73","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/01.ATV.17.10.2020","volume":"17","author":"FY Jin","year":"1997","unstructured":"Jin FY, Kamanna VS, Kashyap ML. Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells. Arterioscler Thromb Vasc Biol. 1997;17:2020\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7281_CR74","doi-asserted-by":"crossref","unstructured":"Fainaru M, Glangeaud MC, Eisenberg S. Radioimmunoassay of human high density lipoprotein apoprotein AI. Biochimica et Biophysica Acta (BBA)-Protein Structure. 1975;386(2):432-43.","DOI":"10.1016\/0005-2795(75)90286-X"},{"key":"7281_CR75","first-page":"1237","volume":"29","author":"S Vallabhajosula","year":"1988","unstructured":"Vallabhajosula S, et al. Radiotracers for Low Density Lipoprotein Biodistribution Studies In Vivo: Technetium-99m Low Density Lipoprotein Versus Radioiodinated Low Density Lipoprotein Preparations. J Nuc\u00c3-Med. 1988;29:1237\u201345.","journal-title":"J Nuc\u00c3-Med"},{"issue":"2","key":"7281_CR76","first-page":"141","volume":"15","author":"SM Moerlein","year":"1988","unstructured":"Moerlein SM, Dalal KB, Ebbe SN, Yano Y, Budinger TF. Residualizing and non-residualizing analogues of low-density lipoprotein as iodine-123 radiopharmaceuticals for imaging LDL catabolism International Journal of Radiation Applications and Instrumentation. Part B Nuclear Med Biol. 1988;15(2):141\u20139.","journal-title":"Part B. Nuclear Med Biol"},{"key":"7281_CR77","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0022-2275(20)37899-8","volume":"24","author":"AB Roberts","year":"1983","unstructured":"Roberts AB, et al. Selective accumulation of low density lipoproteins in damaged arterial wall. J Lipid Res. 1983;24:1160\u20137.","journal-title":"J Lipid Res"},{"key":"7281_CR78","doi-asserted-by":"crossref","unstructured":"Bilheimer DW, Eisenberg S, Levy RI (1972) The metabolism of very low density lipoprotein proteins I Preliminary in vitro and in vivo observations. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism. 260(2):212-21.","DOI":"10.1016\/0005-2760(72)90034-3"},{"key":"7281_CR79","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1172\/JCI110404","volume":"68","author":"RS Munford","year":"1981","unstructured":"Munford RS, Andersen JM, Dietschy JM. Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey. J Clin Invest. 1981;68:1503\u201313.","journal-title":"J Clin Invest"},{"key":"7281_CR80","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0022-2275(20)41312-4","volume":"19","author":"J Shepherd","year":"1978","unstructured":"Shepherd J, Patsch JR, Packard CJ, Gotto AM, Taunton OD. Dynamic properties of human high density lipoprotein apoproteins. J Lipid Res. 1978;19:383\u20139.","journal-title":"J Lipid Res"},{"key":"7281_CR81","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0021-9150(77)90177-0","volume":"28","author":"RL Bratzler","year":"1977","unstructured":"Bratzler RL, Chisolm GM, Colton CK, Smith KA, Lees RS. The distribution of labeled low-density lipoproteins across the rabbit thoracic aorta in vivo. Atherosclerosis. 1977;28:289\u2013307.","journal-title":"Atherosclerosis"},{"issue":"1","key":"7281_CR82","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0022-2275(20)42256-4","volume":"32","author":"DE Atsma","year":"1991","unstructured":"Atsma DE, Kempen HJ, Nieuwenhuizen W, Van\u2019t Hooft FM, Pauwels EK. Partial characterization of low density lipoprotein preparations isolated from fresh and frozen plasma after radiolabeling by seven different methods. J Lipid Res. 1991;32(1):173\u201381.","journal-title":"J Lipid Res"},{"key":"7281_CR83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11745-003-1053-5","volume":"38","author":"B Zhang","year":"2003","unstructured":"Zhang B, Shimoji E, Tanaka H, Saku K. Evaluation of apolipoprotein A-I kinetics in rabbits in vivo using in situ and exogenous radioiodination methods. Lipids. 2003;38:209\u201318.","journal-title":"Lipids"},{"key":"7281_CR84","doi-asserted-by":"publisher","first-page":"7599","DOI":"10.1073\/pnas.81.23.7599","volume":"81","author":"M Huettinger","year":"1984","unstructured":"Huettinger M, et al. Imaging of hepatic low density lipoprotein receptors by radionuclide scintiscanning in vivo. Proc Natl Acad Sci U S A. 1984;81:7599\u2013603.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"7281_CR85","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0022-2275(20)42743-9","volume":"31","author":"R Ramakrishnan","year":"1990","unstructured":"Ramakrishnan R, Arad Y, Wong S, Ginsberg HN. Nonuniform radiolabeling of VLDL apolipoprotein B: implications for the analysis of studies of the kinetics of the metabolism of lipoproteins containing apolipoprotein B. J Lipid Res. 1990;31(6):1031\u201342.","journal-title":"J Lipid Res"},{"key":"7281_CR86","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1172\/JCI107758","volume":"54","author":"G Schonfeld","year":"1974","unstructured":"Schonfeld G, Pfleger B. The Structure of Human High Density Lipoprotein and the Levels of Apolipoprotein A-I in Plasma as Determined by Radioimmunoassay. J Clin Invest. 1974;54:236\u201346.","journal-title":"J Clin Invest"},{"key":"7281_CR87","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nucmedbio.2003.10.010","volume":"31","author":"G Sobal","year":"2004","unstructured":"Sobal G, Resch U, Sinzinger H. Modification of low-density lipoprotein by different radioiodination methods. Nucl Med Biol. 2004;31:381\u20138.","journal-title":"Nucl Med Biol"},{"key":"7281_CR88","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0009-8981(76)90376-4","volume":"66","author":"J Shepherd","year":"1976","unstructured":"Shepherd J, Bedford DK, Morgan HG. Radioiodination of human low density lipoprotein: a comparison of four methods. Clin Chim Acta. 1976;66:97\u2013109.","journal-title":"Clin Chim Acta"},{"key":"7281_CR89","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1042\/bj0890114","volume":"89","author":"FC Greenwood","year":"1963","unstructured":"Greenwood FC, Hunter WM, Glover JS. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem J. 1963;89:114.","journal-title":"Biochem J"},{"key":"7281_CR90","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1042\/bj1130299","volume":"113","author":"JJ Marchalonis","year":"1969","unstructured":"Marchalonis JJ. An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J. 1969;113:299\u2013305.","journal-title":"Biochem J"},{"key":"7281_CR91","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF03179823","volume":"57","author":"JR Romero","year":"2001","unstructured":"Romero JR, Mart\u00ednez R, Fresnedo O, Ochoa B. Comparison of two methods for radioiodination on the oxidizability properties of low density lipoprotein. J Physiol Biochem. 2001;57:291\u2013301.","journal-title":"J Physiol Biochem"},{"key":"7281_CR92","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000055947","volume":"69","author":"A Shaish","year":"2001","unstructured":"Shaish A, Keren G, Chouraqui P, Levkovitz H, Harats D. Imaging of aortic atherosclerotic lesions by 125I-LDL, 125I-oxidized-LDL, 125I-HDL and 125I-BSA. Pathobiology. 2001;69:225\u20139.","journal-title":"Pathobiology"},{"key":"7281_CR93","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0883-2897(91)90112-X","volume":"18","author":"I Virgolini","year":"1991","unstructured":"Virgolini I, et al. Comparison of different methods for LDL isolation and radioiodination on liver LDL receptor binding in vitro. Int J Rad Appl Instrum B. 1991;18:513\u20137.","journal-title":"Int J Rad Appl Instrum B"},{"key":"7281_CR94","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0003-2697(81)90703-X","volume":"117","author":"PRP Salacinski","year":"1981","unstructured":"Salacinski PRP, McLean C, Sykes JEC, Clement-Jones VV, Lowry PJ. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3\u03b1,6\u03b1-diphenyl glycoluril (Iodogen). Anal Biochem. 1981;117:136\u201346.","journal-title":"Anal Biochem"},{"key":"7281_CR95","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1194\/jlr.M200081-JLR200","volume":"43","author":"J Julve","year":"2002","unstructured":"Julve J, et al. Mechanisms of HDL deficiency in mice overexpressing human apoA-II. J Lipid Res. 2002;43:1734\u201342.","journal-title":"J Lipid Res"},{"key":"7281_CR96","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1042\/bj2120791","volume":"212","author":"RC Pittman","year":"1983","unstructured":"Pittman RC, et al. A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J. 1983;212:791\u2013800.","journal-title":"Biochem J"},{"key":"7281_CR97","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0021-9150(85)90004-8","volume":"56","author":"OW Portman","year":"1985","unstructured":"Portman OW, Alexander M. Metabolism of [125I]tyramine cellobiose-labeled low density lipoproteins in squirrel monkeys. Atherosclerosis. 1985;56:283\u201399.","journal-title":"Atherosclerosis"},{"key":"7281_CR98","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S0022-2275(20)32514-1","volume":"39","author":"F Rinninger","year":"1998","unstructured":"Rinninger F, et al. Lipoprotein lipase mediates an increase in the selective uptake of high density lipoprotein-associated cholesteryl esters by hepatic cells in culture. J Lipid Res. 1998;39:1335\u201348.","journal-title":"J Lipid Res"},{"key":"7281_CR99","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1194\/jlr.M500179-JLR200","volume":"46","author":"JY Lee","year":"2005","unstructured":"Lee JY, et al. HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney. J Lipid Res. 2005;46:2233\u201345.","journal-title":"J Lipid Res"},{"key":"7281_CR100","first-page":"300","volume":"32","author":"SM Moerlein","year":"1991","unstructured":"Moerlein SM, Daugherty A, Sobel BE, Welch MJ. Metabolic Imaging with Gallium-68- and Indium-111-Labeled Low-Density Lipoprotein. J Nucl Med. 1991;32:300\u20137.","journal-title":"J Nucl Med"},{"key":"7281_CR101","doi-asserted-by":"publisher","first-page":"14564","DOI":"10.1016\/S0021-9258(17)38605-2","volume":"260","author":"A Daugherty","year":"1985","unstructured":"Daugherty A, Thorpe SR, Lange LG, Sobel BE, Schonfeld G. Loci of catabolism of beta-very low density lipoprotein in vivo delineated with a residualizing label, 125I-dilactitol tyramine. J Biol Chem. 1985;260:14564\u201370.","journal-title":"J Biol Chem"},{"key":"7281_CR102","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1042\/bj1330529","volume":"133","author":"AE Bolton","year":"1973","unstructured":"Bolton AE, Hunter WM. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J. 1973;133:529\u201338.","journal-title":"Biochem J"},{"issue":"9","key":"7281_CR103","first-page":"1056","volume":"26","author":"RS Lees","year":"1985","unstructured":"Lees RS, Garabedian HD, Lees AM, Schumacher DJ, Miller A, Isaacsohn JL, Derksen A, Strauss HW. Technitium-99m Low Density Lipoproteins: Preparation and Biodistribution. J Nucl Med. 1985;26(9):1056\u201362.","journal-title":"J Nucl Med"},{"key":"7281_CR104","doi-asserted-by":"crossref","unstructured":"Lees AM et al. Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins. Arterioslerosis. 1988;5;461\u2013470.","DOI":"10.1161\/01.ATV.8.5.461"},{"issue":"4","key":"7281_CR105","first-page":"333","volume":"50","author":"G Sobal","year":"2006","unstructured":"Sobal G, Resch U, Tatzber F, Sinzinger H. Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods. Quarter J Nucl Med Molecul Imag. 2006;50(4):333\u201343.","journal-title":"Quarter J Nucl Med Molecul Imag"},{"key":"7281_CR106","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1039\/C8NR07484D","volume":"11","author":"K Isaac-Oliv\u00e9","year":"2019","unstructured":"Isaac-Oliv\u00e9 K, et al. [99mTc-HYNIC-N-dodecylamide]: a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging. Nanoscale. 2019;11:541\u201351.","journal-title":"Nanoscale"},{"key":"7281_CR107","first-page":"1","volume":"122\u2013123","author":"DL P\u00e9rez-Velasco","year":"2023","unstructured":"P\u00e9rez-Velasco DL, et al. Biokinetics, radiopharmacokinetics and estimation of the absorbed dose in healthy organs due to Technetium-99m transported in the core and on the surface of reconstituted high-density lipoprotein nanoparticles. Nucl Med Biol. 2023;122\u2013123:1\u201312.","journal-title":"Nucl Med Biol"},{"key":"7281_CR108","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0020-708X(82)90144-2","volume":"33","author":"DJ Hnatowich","year":"1982","unstructured":"Hnatowich DJ, Layne WW, Childs RL. The preparation and labeling of DTPA-coupled albumin. Int J Appl Radiat Isot. 1982;33:327\u201332.","journal-title":"Int J Appl Radiat Isot"},{"key":"7281_CR109","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/01.ATV.12.7.849","volume":"12","author":"I Virgolini","year":"1992","unstructured":"Virgolini I, et al. Binding of 111In-labeled HDL to platelets from normolipemic volunteers and patients with heterozygous familial hypercholesterolemia. Arterioscler Thromb. 1992;12:849\u201361.","journal-title":"Arterioscler Thromb"},{"key":"7281_CR110","first-page":"343","volume":"31","author":"JM Rosen","year":"1990","unstructured":"Rosen JM, et al. Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution. J Nucl Med. 1990;31:343\u201350.","journal-title":"J Nucl Med"},{"key":"7281_CR111","first-page":"1289","volume":"22","author":"T Leitha","year":"1995","unstructured":"Leitha T, Staltdenherz A, Hermann M, Hottinger M, Gmeiner B. Parenchymal and nonparenchymal uptake of technetium-99m, indium-111, and iodine-125 low-density lipoprotein in the normal and estradiol-stimulated rat liver: tracer validation for quantitative low-density lipoprotein scintigraphy. Hepatology. 1995;22:1289\u201395.","journal-title":"Hepatology"},{"key":"7281_CR112","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/sj.gt.3302206","volume":"11","author":"UJF Tietge","year":"2004","unstructured":"Tietge UJF, et al. A sensitive noninvasive method for monitoring successful liver-directed gene transfer of the low-density lipoprotein receptor in Watanabe hyperlipidemic rabbits in vivo. Gene Ther. 2004;11:574\u201380.","journal-title":"Gene Ther"},{"key":"7281_CR113","first-page":"2132","volume":"32","author":"I Virgolini","year":"1991","unstructured":"Virgolini I, et al. Indium-111-Labeled Low-Density Lipoprotein Binds with Higher Affinity to the Human Liver as Compared to Iodine-123-Low-Density-Labeled Lipoprotein. J Nucl Med. 1991;32:2132\u20138.","journal-title":"J Nucl Med"},{"key":"7281_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.140280","volume":"5","author":"T Hadi","year":"2020","unstructured":"Hadi T, et al. Lipoproteins LDL versus HDL as nanocarriers to target either cancer cells or macrophages. JCI Insight. 2020;5:1\u201314.","journal-title":"JCI Insight"},{"key":"7281_CR115","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.2967\/jnumed.115.158956","volume":"56","author":"C Perez-Medina","year":"2015","unstructured":"Perez-Medina C, et al. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles. J Nucl Med. 2015;56:1272\u20137.","journal-title":"J Nucl Med"},{"key":"7281_CR116","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jcmg.2016.01.020","volume":"9","author":"C P\u00e9rez-Medina","year":"2016","unstructured":"P\u00e9rez-Medina C, et al. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. JACC Cardiovasc Imaging. 2016;9:950\u201361.","journal-title":"JACC Cardiovasc Imaging"},{"key":"7281_CR117","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/ATVBAHA.119.313455","volume":"40","author":"C P\u00e9rez-Medina","year":"2020","unstructured":"P\u00e9rez-Medina C, Fayad ZA, Mulder WJM. Atherosclerosis Immunoimaging by Positron Emission Tomography. Arterioscler Thromb Vasc Biol. 2020;40:865\u201373.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7281_CR118","doi-asserted-by":"publisher","first-page":"6731","DOI":"10.1073\/pnas.1609629113","volume":"113","author":"J Tang","year":"2016","unstructured":"Tang J, et al. Immune cell screening of a nanoparticle library improves atherosclerosis therapy. Proceed Natl Acad Sci. 2016;113:6731\u201340.","journal-title":"Proceed Natl Acad Sci"},{"key":"7281_CR119","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41565-020-0642-4","volume":"15","author":"ML Senders","year":"2020","unstructured":"Senders ML, et al. Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging. Nat Nanotechnol. 2020;15:398\u2013405.","journal-title":"Nat Nanotechnol"},{"key":"7281_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41181-024-00258-y","volume":"9","author":"TE Wuensche","year":"2024","unstructured":"Wuensche TE, Lyashchenko S, van Dongen GAMS, Vugts D. Good practices for 89Zr radiopharmaceutical production and quality control. EJNMMI Radiopharm Chem. 2024;9:1\u201321.","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"17","key":"7281_CR121","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.3390\/cancers13174466","volume":"13","author":"IV Feiner","year":"2021","unstructured":"Feiner IV, Brandt M, Cowell J, Demuth T, Vugts D, Gasser G, Mindt TL. The Race for Hydroxamate-Based Zirconium-89 Chelators. Cancers. 2021;13(17):4466.","journal-title":"Cancers"},{"key":"7281_CR122","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/CIRCIMAGING.113.000607","volume":"7","author":"C Jung","year":"2014","unstructured":"Jung C, et al. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice. Circ Cardiovasc Imaging. 2014;7:303\u201311.","journal-title":"Circ Cardiovasc Imaging"},{"key":"7281_CR123","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0022-2275(20)39140-9","volume":"37","author":"D Masson","year":"1996","unstructured":"Masson D, Athias A, Lagrost L. Evidence for electronegativity of plasma high density lipoprotein-3 as one major determinant of human cholesteryl ester transfer protein activity. J Lipid Res. 1996;37:1579\u201390.","journal-title":"J Lipid Res"},{"key":"7281_CR124","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1194\/jlr.M011981","volume":"52","author":"M Brundert","year":"2011","unstructured":"Brundert M, et al. Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells. J Lipid Res. 2011;52:745\u201358.","journal-title":"J Lipid Res"},{"key":"7281_CR125","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/01.ATV.0000229219.13757.a2","volume":"26","author":"RR Singaraja","year":"2006","unstructured":"Singaraja RR, et al. Hepatic ATP-binding cassette transporter A1 is a key molecule in high-density lipoprotein cholesteryl ester metabolism in mice. Arterioscler Thromb Vasc Biol. 2006;26:1821\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7281_CR126","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0005-2760(80)90206-4","volume":"620","author":"O Stein","year":"1980","unstructured":"Stein O, Halperin G, Stein Y. Biological labeling of very low density lipoproteins with cholesteryl linoleyl ether and its fate in the intact rat. Biochim Biophys Acta. 1980;620:247\u201360.","journal-title":"Biochim Biophys Acta"},{"key":"7281_CR127","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0022-2275(20)41391-4","volume":"33","author":"H Kadowaki","year":"1992","unstructured":"Kadowaki H, Patton GM, Robins SJ. Metabolism of high density lipoprotein lipids by the rat liver: evidence for participation of hepatic lipase in the uptake of cholesteryl ester. J Lipid Res. 1992;33:1689\u201398.","journal-title":"J Lipid Res"},{"key":"7281_CR128","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1172\/JCI111477","volume":"74","author":"C Edelstein","year":"1984","unstructured":"Edelstein C, et al. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma. J Clin Invest. 1984;74:1098\u2013103.","journal-title":"J Clin Invest"},{"key":"7281_CR129","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1016\/S0021-9258(18)32773-X","volume":"258","author":"JI Gordon","year":"1983","unstructured":"Gordon JI, et al. Proteolytic processing of human preproapolipoprotein A-I A proposed defect in the conversion of pro A-I to A-I. in Tangier\u2019s disease. J Biol Chem. 1983;258:4037\u201344.","journal-title":"J Biol Chem"},{"key":"7281_CR130","doi-asserted-by":"crossref","unstructured":"Portman OW, Illingworth DR, Alexander M (1975) The effects of hyperlipidemia on lbpoprotein metabolism in squirrel monkeys and rabbits. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 398, 55\u201371","DOI":"10.1016\/0005-2760(75)90169-1"},{"key":"7281_CR131","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0021-9150(94)90123-6","volume":"106","author":"T Sasahara","year":"1994","unstructured":"Sasahara T, et al. The metabolic fate of apolipoprotein A-I-containing lipoproteins internalized into HepG2 cells: resecreted lipoproteins as a potent inducer for cholesterol efflux. Atherosclerosis. 1994;106:179\u201390.","journal-title":"Atherosclerosis"},{"key":"7281_CR132","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.nucmedbio.2004.08.009","volume":"31","author":"J Pietzsch","year":"2004","unstructured":"Pietzsch J, et al. Fluorine-18 radiolabeling of low-density lipoproteins: a potential approach for characterization and differentiation of metabolism of native and oxidized low-density lipoproteins in vivo. Nucl Med Biol. 2004;31:1043\u201350.","journal-title":"Nucl Med Biol"},{"key":"7281_CR133","doi-asserted-by":"crossref","unstructured":"Paulus A et al. (2019) [18F]BODIPY-triglyceride-containing chylomicron-like particles as an imaging agent for brown adipose tissue in vivo. Scientif Rep 1 9, 1\u20139 (2019).","DOI":"10.1038\/s41598-019-39561-z"},{"key":"7281_CR134","doi-asserted-by":"crossref","unstructured":"Nicoll A, Lewis B. Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man. Eur J Clinic Investig. 1980;10:487\u2013495.","DOI":"10.1111\/j.1365-2362.1980.tb02090.x"},{"key":"7281_CR135","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1021\/bi00507a059","volume":"20","author":"VI Zannis","year":"1981","unstructured":"Zannis VI, Breslow JL. Human Very Low Density Lipoprotein Apolipoprotein E Isoprotein Polymorphism Is Explained by Genetic Variation and Posttranslational Modification. Biochemistry. 1981;20:1033\u201341.","journal-title":"Biochemistry"},{"key":"7281_CR136","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0022-2275(20)38094-9","volume":"23","author":"VI Zannis","year":"1982","unstructured":"Zannis VI, et al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res. 1982;23:911\u20134.","journal-title":"J Lipid Res"},{"key":"7281_CR137","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/iub.1314","volume":"66","author":"MC Phillips","year":"2014","unstructured":"Phillips MC. Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life. 2014;66:616\u201323.","journal-title":"IUBMB Life"},{"key":"7281_CR138","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1172\/JCI108833","volume":"60","author":"CB Blum","year":"1977","unstructured":"Blum CB, et al. High Density Lipoprotein Metabolism in Man. J Clin Invest. 1977;60:795\u2013807.","journal-title":"J Clin Invest"},{"key":"7281_CR139","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1172\/JCI109078","volume":"6","author":"J Shepherd","year":"1978","unstructured":"Shepherd J, Packard CJ, Patsch JR, Gotto AM, Taunton JD. Effects of Dietary Polyunsaturated and Saturated Fat on the Properties of High Density Lipoproteins and the Metabolism of Apolipoprotein A-I. J Clinic Investigat. 1978;6:1582\u201392.","journal-title":"J Clinic Investigat"},{"key":"7281_CR140","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MOL.0000000000000139","volume":"26","author":"B Lamarche","year":"2015","unstructured":"Lamarche B, Couture P. Dietary fatty acids, dietary patterns, and lipoprotein metabolism. Curr Opin Lipidol. 2015;26:42\u20137.","journal-title":"Curr Opin Lipidol"},{"key":"7281_CR141","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/CIR.0000000000001031","volume":"144","author":"AH Lichtenstein","year":"2021","unstructured":"Lichtenstein AH, et al. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement from the American Heart Association. Circulation. 2021;144:472\u201387.","journal-title":"Circulation"},{"key":"7281_CR142","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1056\/NEJMp078058","volume":"356","author":"S Okie","year":"2007","unstructured":"Okie S. New York to Trans Fats: You\u2019re Out! N Engl J Med. 2007;356:2017\u201321.","journal-title":"N Engl J Med"},{"key":"7281_CR143","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1016\/S0021-9258(19)42341-7","volume":"249","author":"JL Goldstein","year":"1974","unstructured":"Goldstein JL, Brown MS. Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts: comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974;249:5153\u201362.","journal-title":"J Biol Chem"},{"key":"7281_CR144","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1073\/pnas.71.3.788","volume":"71","author":"MS Brown","year":"1974","unstructured":"Brown MS, Goldstein JL. Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3 hydroxy 3 methylglutaryl coenzyme A reductase activity. Proc Natl Acad Sci. 1974;71:788\u201392.","journal-title":"Proc Natl Acad Sci"},{"key":"7281_CR145","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/01.ATV.0000149381.16166.c6","volume":"25","author":"M Brundert","year":"2005","unstructured":"Brundert M, et al. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice. Arterioscler Thromb Vasc Biol. 2005;25:143\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"351","key":"7281_CR146","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1126\/science.aad3517","volume":"1979","author":"P Zanoni","year":"2016","unstructured":"Zanoni P, et al. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science. 2016;1979(351):1166\u201371.","journal-title":"Science"},{"key":"7281_CR147","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1194\/jlr.M700355-JLR200","volume":"49","author":"M Van Eck","year":"2008","unstructured":"Van Eck M, et al. Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo. J Lipid Res. 2008;49:136\u201346.","journal-title":"J Lipid Res"},{"key":"7281_CR148","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa1001689","volume":"364","author":"AV Khera","year":"2011","unstructured":"Khera AV, et al. Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis. N Engl J Med. 2011;364:127\u201335.","journal-title":"N Engl J Med"},{"key":"7281_CR149","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","volume":"33","author":"XM Li","year":"2013","unstructured":"Li XM, et al. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks. Arterioscler Thromb Vasc Biol. 2013;33:1696\u2013705.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7281_CR150","doi-asserted-by":"crossref","unstructured":"Low H, Hoang A, Sviridov D. Cholesterol efflux assay. J Visualized Exp. 2012;61;3791\u20133810.","DOI":"10.3791\/3810-v"},{"key":"7281_CR151","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.1074\/jbc.273.10.5599","volume":"273","author":"B Jian","year":"1998","unstructured":"Jian B, et al. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem. 1998;273:5599\u2013606.","journal-title":"J Biol Chem"},{"key":"7281_CR152","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1172\/JCI116663","volume":"92","author":"S Ishibashi","year":"1993","unstructured":"Ishibashi S, et al. Hypercholesterolemia in Low Density Lipoprotein Receptor Knockout Mice and its Reversal by Adenovirus-mediated Gene Delivery. J Clin Investig. 1993;92:883\u201393.","journal-title":"J Clin Investig"},{"key":"7281_CR153","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/01.ATV.20.4.1068","volume":"20","author":"D Huszar","year":"2000","unstructured":"Huszar D, et al. Increased LDL Cholesterol and Atherosclerosis in LDL Receptor-Deficient Mice With Attenuated Expression of Scavenger Receptor B1. Arterioscler Thromb Vasc Biol. 2000;20:1068\u201373.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7281_CR154","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1194\/jlr.M038877","volume":"54","author":"XP Yang","year":"2013","unstructured":"Yang XP, et al. Scavenger receptor-BI is a receptor for lipoprotein(a). J Lipid Res. 2013;54:2450\u20137.","journal-title":"J Lipid Res"},{"key":"7281_CR155","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/cvr\/cvs136","volume":"94","author":"R Cal","year":"2012","unstructured":"Cal R, et al. Low-density lipoprotein receptor-related protein 1 mediates hypoxia-induced very low density lipoprotein-cholesteryl ester uptake and accumulation in cardiomyocytes. Cardiovasc Res. 2012;94:469\u201379.","journal-title":"Cardiovasc Res"},{"key":"7281_CR156","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1113\/jphysiol.2009.173542","volume":"587","author":"YG Niu","year":"2009","unstructured":"Niu YG, Evans RD. Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes. J Physiol. 2009;587:3301\u201315.","journal-title":"J Physiol"},{"key":"7281_CR157","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1172\/JCI118082","volume":"96","author":"GA Francis","year":"1995","unstructured":"Francis GA, Knopp RH, Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J Clin Invest. 1995;96:78\u201387.","journal-title":"J Clin Invest"},{"key":"7281_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20030544","volume":"20","author":"N Potere","year":"2019","unstructured":"Potere N, et al. Developing LRP1 Agonists into a Therapeutic Strategy in Acute Myocardial Infarction. Int J Mol Sci. 2019;20:1\u201318.","journal-title":"Int J Mol Sci"},{"key":"7281_CR159","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0021-9150(99)00341-X","volume":"149","author":"SD Proctor","year":"2000","unstructured":"Proctor SD, Pabla CK, Mamo JCL. Arterial intimal retention of pro-atherogenic lipoproteins in insulin deficient rabbits and rats. Atherosclerosis. 2000;149:315\u201322.","journal-title":"Atherosclerosis"},{"key":"7281_CR160","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0026-0495(77)90093-2","volume":"26","author":"TG Redgrave","year":"1977","unstructured":"Redgrave TG, Snibson DA. Clearance of chylomicron triacylglycerol and cholesteryl ester from the plasma of streptozotocin-induced diabetic and hypercholesterolemic hypothyroid rats. Metabolism. 1977;26:493\u2013503.","journal-title":"Metabolism"},{"key":"7281_CR161","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1152\/ajpendo.90260.2008","volume":"295","author":"YG Niu","year":"2008","unstructured":"Niu YG, Evans RD. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: Effects of diabetes and lipoprotein preference. Am J Physiol Endocrinol Metab. 2008;295:1106\u201316.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7281_CR162","doi-asserted-by":"crossref","unstructured":"Unger RH, Orci L (2002) Lipoapoptosis: its mechanism and its diseases. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 1585(2-3):202-12.","DOI":"10.1016\/S1388-1981(02)00342-6"},{"key":"7281_CR163","doi-asserted-by":"crossref","unstructured":"Zlobine I, Gopal K, Ussher JR (2016) Lipotoxicity in obesity and diabetes-related cardiac dysfunction. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 1861(10):1555-68.","DOI":"10.1016\/j.bbalip.2016.02.011"},{"key":"7281_CR164","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/cvr\/cvr212","volume":"92","author":"T Van De Weijer","year":"2011","unstructured":"Van De Weijer T, Schrauwen-Hinderling VB, Schrauwen P. Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res. 2011;92:10\u20138.","journal-title":"Cardiovasc Res"},{"key":"7281_CR165","doi-asserted-by":"publisher","first-page":"802","DOI":"10.5551\/jat.RV17053","volume":"28","author":"M Koseki","year":"2021","unstructured":"Koseki M, et al. Current Diagnosis and Management of Tangier Disease. J Atheroscler Thromb. 2021;28:802\u201310.","journal-title":"J Atheroscler Thromb"},{"key":"7281_CR166","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/MOL.0000000000000669","volume":"31","author":"AJ Hooper","year":"2020","unstructured":"Hooper AJ, Hegele RA, Burnett JR. Tangier disease: update for 2020. Curr Opin Lipidol. 2020;31:80\u20134.","journal-title":"Curr Opin Lipidol"},{"key":"7281_CR167","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S0022-2275(20)32019-8","volume":"41","author":"ME Brousseau","year":"2000","unstructured":"Brousseau ME, et al. Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. J Lipid Res. 2000;41:1125\u201335.","journal-title":"J Lipid Res"},{"key":"7281_CR168","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1053\/meta.2000.6243","volume":"49","author":"S Schuler-Luttmann","year":"2000","unstructured":"Schuler-Luttmann S, et al. Cholesterol efflux from normal and Tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas. Metabolism. 2000;49:770\u20137.","journal-title":"Metabolism"},{"key":"7281_CR169","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/01.ATV.15.5.683","volume":"15","author":"G Rogler","year":"1995","unstructured":"Rogler G, Tr\u00fcmbach B, Klima B, Lackner KJ, Schmitz G. HDL-Mediated Efflux of Intracellular Cholesterol Is Impaired in Fibroblasts From Tangier Disease Patients. Arterioscler Thromb Vasc Biol. 1995;15:683\u201390.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7281_CR170","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1172\/JCI8509","volume":"104","author":"HH Hobbs","year":"1999","unstructured":"Hobbs HH, Rader DJ. ABC1: connecting yellow tonsils, neuropathy, and very low HDL. J Clin Invest. 1999;104:1015\u20137.","journal-title":"J Clin Invest"},{"key":"7281_CR171","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000055947","volume":"69","author":"A Shaish","year":"2002","unstructured":"Shaish A, Keren G, Chouraqui P, Levkovitz H, Harats D. Imaging of Aortic Atherosclerotic Lesions by 125I-LDL, 125I-Oxidized-LDL, 125I-HDL and 125I-BSA. Pathobiology. 2002;69:225\u20139.","journal-title":"Pathobiology"},{"key":"7281_CR172","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00249-003-0334-7","volume":"33","author":"Z Boz\u00f3ky","year":"2004","unstructured":"Boz\u00f3ky Z, et al. Preparation and investigation of 99m technetium-labeled low-density lipoproteins in rabbits with experimentally induced hypercholesterolemia. Eur Biophys J. 2004;33:140\u20135.","journal-title":"Eur Biophys J"},{"key":"7281_CR173","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejmech.2019.05.002","volume":"176","author":"J Yong-Sang","year":"2019","unstructured":"Yong-Sang J, et al. Development, synthesis, and 68Ga-Labeling of a Lipophilic complexing agent for atherosclerosis PET imaging. Eur J Med Chem. 2019;176:129\u201334.","journal-title":"Eur J Med Chem"},{"key":"7281_CR174","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2016.05.038","volume":"251","author":"KH Zheng","year":"2016","unstructured":"Zheng KH, et al. HDL mimetic CER-001 targets atherosclerotic plaques in patients. Atherosclerosis. 2016;251:381\u20138.","journal-title":"Atherosclerosis"},{"key":"7281_CR175","doi-asserted-by":"crossref","unstructured":"Toner YC, Pr\u00e9vot G, van Leent MM, Munitz J, Oosterwijk R, Verschuur AV, et al. Macrophage PET imaging in mouse models of cardiovascular disease and cancer with an apolipoprotein-inspired radiotracer. npj Imaging. 2024;2(1):12.","DOI":"10.1038\/s44303-024-00009-3"},{"key":"7281_CR176","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40487-022-00214-3","volume":"11","author":"E Allison","year":"2023","unstructured":"Allison E, Edirimanne S, Matthews J, Fuller SJ. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis. Oncol Ther. 2023;11:27\u201348.","journal-title":"Oncol Ther"},{"key":"7281_CR177","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1152\/ajpheart.2000.278.6.H1874","volume":"278","author":"N Sambandam","year":"2000","unstructured":"Sambandam N, et al. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts. Am J Physiol Heart Circ Physiol. 2000;278:1874\u201382.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7281_CR178","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/01.ATV.18.12.1927","volume":"18","author":"T Bj\u00f6rnheden","year":"1998","unstructured":"Bj\u00f6rnheden T, Bondjers G, Wiklund O. Direct Assessment of Lipoprotein Outflow From In Vivo-Labeled Arterial Tissue as Determined in an In Vitro Perfusion System. Arterioscler Thromb Vasc Biol. 1998;18:1927\u201333.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7281_CR179","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0021-9258(17)43665-9","volume":"259","author":"JC Osborne","year":"1984","unstructured":"Osborne JC, Schaefer EJ, Powell GM, Lee NS, Zech LA. Molecular Properties of Radioiodinated Apolipoprotein A-I. J Biol Chem. 1984;259:347\u201353.","journal-title":"J Biol Chem"},{"key":"7281_CR180","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0022-2275(20)35365-7","volume":"22","author":"EJ Schaefer","year":"1981","unstructured":"Schaefer EJ, et al. Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins. J Lipid Res. 1981;22:217\u201328.","journal-title":"J Lipid Res"},{"key":"7281_CR181","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1172\/JCI114819","volume":"86","author":"RJ Owens","year":"1990","unstructured":"Owens RJ, et al. Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation. J Clin Invest. 1990;86:1142\u201350.","journal-title":"J Clin Invest"},{"key":"7281_CR182","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1194\/jlr.M200475-JLR200","volume":"44","author":"AT Remaley","year":"2003","unstructured":"Remaley AT, et al. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J Lipid Res. 2003;44:828\u201336.","journal-title":"J Lipid Res"},{"key":"7281_CR183","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/bph.12174","volume":"169","author":"A Tran-Dinh","year":"2013","unstructured":"Tran-Dinh A, et al. HDL and endothelial protection. Br J Pharmacol. 2013;169:493.","journal-title":"Br J Pharmacol"},{"key":"7281_CR184","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1161\/01.ATV.0000094961.74697.54","volume":"23","author":"L Calabresi","year":"2003","unstructured":"Calabresi L, Gomaraschi M, Franceschini G. Endothelial Protection by High-Density Lipoproteins. Arterioscler Thromb Vasc Biol. 2003;23:1724\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7281_CR185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2015.00222","volume":"6","author":"H Soran","year":"2015","unstructured":"Soran H, Schofield JD, Durrington PN. Antioxidant properties of HDL. Front Pharmacol. 2015;6:1\u20136.","journal-title":"Front Pharmacol"},{"key":"7281_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.CIR.0000131512.50667.46","volume":"109","author":"G Assmann","year":"2004","unstructured":"Assmann G, Gotto AM. HDL Cholesterol and Protective Factors in Atherosclerosis. Circulation. 2004;109:1\u20137.","journal-title":"Circulation"},{"key":"7281_CR187","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","volume":"384","author":"DJ Rader","year":"2014","unstructured":"Rader DJ, Hovingh GK. HDL and cardiovascular disease. The Lancet. 2014;384:618\u201325.","journal-title":"The Lancet"},{"key":"7281_CR188","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1161\/CIRCULATIONAHA.113.002683","volume":"128","author":"BA Kingwell","year":"2013","unstructured":"Kingwell BA, Chapman MJ. Future of high-density lipoprotein infusion therapies: Potential for clinical management of vascular disease. Circulation. 2013;128:1112\u201321.","journal-title":"Circulation"},{"key":"7281_CR189","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.108.182063","volume":"103","author":"JA Shaw","year":"2008","unstructured":"Shaw JA, et al. Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque. Circ Res. 2008;103:1084\u201391.","journal-title":"Circ Res"},{"key":"7281_CR190","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11883-023-01176-1","volume":"25","author":"F Begue","year":"2023","unstructured":"Begue F, Apalama ML, Lambert G, Meilhac O. HDL as a Treatment Target: Should We Abandon This Idea? Curr Atheroscler Rep. 2023;25:1093\u20139.","journal-title":"Curr Atheroscler Rep"},{"key":"7281_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11886-018-1004-9","volume":"20","author":"I Karalis","year":"2018","unstructured":"Karalis I, Jukema JW. HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option? Curr Cardiol Rep. 2018;20:1\u20138.","journal-title":"Curr Cardiol Rep"},{"key":"7281_CR192","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2020.08.004","volume":"311","author":"KH Zheng","year":"2020","unstructured":"Zheng KH, et al. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis. 2020;311:13\u20139.","journal-title":"Atherosclerosis"},{"key":"7281_CR193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-46811-8","volume":"13","author":"O Chehab","year":"2023","unstructured":"Chehab O, et al. Higher HDL cholesterol levels are associated with increased markers of interstitial myocardial fibrosis in the MultiEthnic Study of Atherosclerosis (MESA). Sci Rep. 2023;13:1\u20139.","journal-title":"Sci Rep"},{"key":"7281_CR194","first-page":"1","volume":"10","author":"M Casula","year":"2021","unstructured":"Casula M, Colpani O, Xie S, Catapano AL, Baragetti A. HDL in Atherosclerotic Cardiovascular Disease. In Search of a Role Cells. 2021;10:1\u201317.","journal-title":"In Search of a Role Cells"},{"key":"7281_CR195","first-page":"1","volume":"2025","author":"SRJ Hofstraat","year":"2025","unstructured":"Hofstraat SRJ, et al. Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors. Nat Nanotechnol. 2025;2025:1\u201311.","journal-title":"Nat Nanotechnol"},{"key":"7281_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules27072156","volume":"27","author":"T Hern\u00e1ndez-Jim\u00e9nez","year":"2022","unstructured":"Hern\u00e1ndez-Jim\u00e9nez T, et al. 225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins. Molecules. 2022;27:1\u201315.","journal-title":"Molecules"},{"key":"7281_CR197","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.immuni.2018.09.008","volume":"49","author":"MS Braza","year":"2018","unstructured":"Braza MS, et al. Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance. Immunity. 2018;49:819\u201328.","journal-title":"Immunity"},{"key":"7281_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aaw7736","volume":"11","author":"T Binderup","year":"2019","unstructured":"Binderup T, et al. Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species. Sci Transl Med. 2019;11:1\u201313.","journal-title":"Sci Transl Med"},{"key":"7281_CR199","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1021\/nl1041947","volume":"11","author":"KM McMahon","year":"2011","unstructured":"McMahon KM, et al. Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. Nano Lett. 2011;11:1208\u201314.","journal-title":"Nano Lett"},{"key":"7281_CR200","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/nbt1339","volume":"25","author":"C Wolfrum","year":"2007","unstructured":"Wolfrum C, et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat Biotechnol. 2007;25:1149\u201357.","journal-title":"Nat Biotechnol"},{"key":"7281_CR201","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/mt.2012.33","volume":"20","author":"T Nakayama","year":"2012","unstructured":"Nakayama T, et al. Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particles. Mol Ther. 2012;20:1582\u20139.","journal-title":"Mol Ther"},{"key":"7281_CR202","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.addr.2020.07.017","volume":"154","author":"C P\u00e9rez-Medina","year":"2020","unstructured":"P\u00e9rez-Medina C, Teunissen AJP, Kluza E, Mulder WJM, van der Meel R. Nuclear imaging approaches facilitating nanomedicine translation. Adv Drug Deliv Rev. 2020;154:123\u201341.","journal-title":"Adv Drug Deliv Rev"},{"key":"7281_CR203","doi-asserted-by":"crossref","unstructured":"Schrijver DP et al. Nanoengineering apolipoprotein A1-based immunotherapeutics. Adv Therap. 2021;4:1\u20136.","DOI":"10.1002\/adtp.202100083"},{"key":"7281_CR204","first-page":"1","volume":"13","author":"MMT Van Leent","year":"2021","unstructured":"Van Leent MMT, et al. Prosaposin mediates inflammation in atherosclerosis. Sci Transl Med. 2021;13:1\u201313.","journal-title":"Sci Transl Med"},{"key":"7281_CR205","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.2967\/jnumed.120.255794","volume":"62","author":"E Aluicio-Sarduy","year":"2021","unstructured":"Aluicio-Sarduy E, Barnhart TE, Weichert J, Hernandez R, Engle JW. Cyclotron-Produced 132La as a PET Imaging Surrogate for Therapeutic 225Ac. J Nucl Med. 2021;62:1012\u20135.","journal-title":"J Nucl Med"},{"key":"7281_CR206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41551-023-01060-y","volume":"7","author":"EC Pratt","year":"2023","unstructured":"Pratt EC, et al. Simultaneous quantitative imaging of two PET radiotracers via the detection of positron\u2013electron annihilation and prompt gamma emissions. Nat Biomed Eng. 2023;7:1\u201312.","journal-title":"Nat Biomed Eng"},{"key":"7281_CR207","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2967\/jnumed.116.184028","volume":"59","author":"SR Cherry","year":"2018","unstructured":"Cherry SR, et al. Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care. J Nucl Med. 2018;59:3\u201312.","journal-title":"J Nucl Med"},{"key":"7281_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/diagnostics12020426","volume":"12","author":"S Katal","year":"2022","unstructured":"Katal S, Eibschutz LS, Saboury B, Gholamrezanezhad A, Alavi A. Advantages and Applications of Total-Body PET Scanning. Diagnostics. 2022;12:1\u201313.","journal-title":"Diagnostics"},{"key":"7281_CR209","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","volume":"297","author":"J-C Tardif","year":"2007","unstructured":"Tardif J-C, et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA. 2007;297:1675\u201382.","journal-title":"JAMA"},{"key":"7281_CR210","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1093\/eurheartj\/ehu171","volume":"35","author":"J-C Tardif","year":"2014","unstructured":"Tardif J-C, et al. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur Heart J. 2014;35:3277\u201386.","journal-title":"Eur Heart J"},{"key":"7281_CR211","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrcardio.2010.200","volume":"8","author":"EM Degoma","year":"2011","unstructured":"Degoma EM, Rader DJ. Novel HDL-directed pharmacotherapeutic strategies. Nat Rev Cardiol. 2011;8:266\u201377.","journal-title":"Nat Rev Cardiol"},{"key":"7281_CR212","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejpb.2011.01.005","volume":"78","author":"M De Jesus","year":"2011","unstructured":"De Jesus M, Wurm FM. Manufacturing recombinant proteins in kg-ton quantities using animal cells in bioreactors. Eur J Pharm Biopharm. 2011;78:184\u20138.","journal-title":"Eur J Pharm Biopharm"},{"key":"7281_CR213","doi-asserted-by":"publisher","first-page":"2307502","DOI":"10.1002\/smll.202307502","volume":"20","author":"J Morla-Folch","year":"2024","unstructured":"Morla-Folch J, Ranzenigo A, Fayad ZA, Teunissen AJP. Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions. Small. 2024;20:2307502.","journal-title":"Small"},{"key":"7281_CR214","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1038\/s41467-022-34750-3","volume":"13","author":"JY Han","year":"2022","unstructured":"Han JY, La Fiandra JN, DeVoe DL. Microfluidic vortex focusing for high throughput synthesis of size-tunable liposomes. Nat, Comm. 2022;13:6997\u20137008.","journal-title":"Nat, Comm"},{"key":"7281_CR215","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pharmthera.2015.10.010","volume":"157","author":"M Darabi","year":"2016","unstructured":"Darabi M, Guillas-Baudouin I, Le Goff W, Chapman MJ, Kontush A. Therapeutic applications of reconstituted HDL: When structure meets function. Pharmacol Ther. 2016;157:28\u201342.","journal-title":"Pharmacol Ther"},{"key":"7281_CR216","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s12257-010-0421-4","volume":"16","author":"JS Kim","year":"2011","unstructured":"Kim JS, Kang Y, Son KH, Choi SM, Kim KY. Manufacturing and shelf stability of reconstituted high-density lipoprotein for infusion therapy. Biotechnol Bioprocess Eng. 2011;16:785\u201392.","journal-title":"Biotechnol Bioprocess Eng"},{"key":"7281_CR217","doi-asserted-by":"publisher","first-page":"146","DOI":"10.14797\/mdcj-12-3-146","volume":"12","author":"HJ Pownall","year":"2016","unstructured":"Pownall HJ, Rosales C, Gillard BK, Ferrari M. Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism. Methodist Debakey Cardiovasc J. 2016;12:146\u201351.","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"7281_CR218","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1194\/jlr.M060285","volume":"56","author":"A Schwendeman","year":"2015","unstructured":"Schwendeman A, et al. The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties. J Lipid Res. 2015;56:1727.","journal-title":"J Lipid Res"},{"key":"7281_CR219","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1096\/fj.09-139865","volume":"24","author":"W Chen","year":"2010","unstructured":"Chen W, et al. RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe. FASEB J. 2010;24:1689\u201399.","journal-title":"FASEB J"},{"key":"7281_CR220","doi-asserted-by":"publisher","first-page":"8002","DOI":"10.1016\/j.biomaterials.2014.05.081","volume":"35","author":"L Liu","year":"2014","unstructured":"Liu L, et al. Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions. Biomaterials. 2014;35:8002\u201314.","journal-title":"Biomaterials"},{"key":"7281_CR221","doi-asserted-by":"publisher","first-page":"7668","DOI":"10.1039\/C7CS00492C","volume":"46","author":"C Zhu","year":"2017","unstructured":"Zhu C, Xia Y. Biomimetics: reconstitution of low-density lipoprotein for targeted drug delivery and related theranostic applications. Chem Soc Rev. 2017;46:7668\u201382.","journal-title":"Chem Soc Rev"},{"key":"7281_CR222","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/ATVBAHA.123.319742","volume":"44","author":"AB Andraski","year":"2024","unstructured":"Andraski AB, Sacks FM, Aikawa M, Singh SA. Understanding HDL Metabolism and Biology Through in Vivo Tracer Kinetics. Arterioscler Thromb Vasc Biol. 2024;44:76\u201388.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07281-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07281-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07281-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:02:58Z","timestamp":1759399378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07281-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":222,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7281"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07281-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We declare no competing interests. This article does not contain any new studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a systematic literature review; therefore, no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}